TGFB1 and neoplasm: At the genomic level, a recent study using a “pan-cancer cohort” that involves 9125 tumor samples across 33 cancer types in TCGA (The Cancer Genome Atlas) has revealed that 39% of the samples bear genomic alterations of the TGF-β family pathways [62].